Endophthalmitis After Intravitreous Anti-VEGF Injections in Patients Receiving vs. Not Receiving Topical Antibiotics

• Status: Unknown status
• Trial end date: 2017-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective case series which aims to determine the incidence of endophthalmitis following intravitreous anti-vascular endothelial growth factor (VEGF) injection comparing between eyes receiving post-injection antibiotics drops and those not receiving antibiotics drops treated at Chiang Mai University Hospital between May 2015 and April 2017 (2-year period).

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chiang Mai University
• Treatments: Anti-Bacterial Agents; Antibiotics, Antitubercular; Endothelial Growth Factors; Polystyrene sulfonic acid

Criteria

Inclusion Criteria:

1. More than 18 years of age

2. Have an eye conditions requiring intravitreous anti-VEGF injections, including neovascular age-related macular degeneration, diabetic macular edema, macular edema due to retinal vein occlusions in one or both eyes

3. Able to revisit for an eye evaluation at a recommended period (at least 3 weeks following the injection)

4. No history of uveitis or endophthalmitis in the study eye

Exclusion Criteria:

• Presence of blepharitis or conjunctivitis in the study at the time of intravitreous injection